Brian Mueller
CIK 1514980 · EVP, Chief Financial Officer · last filed 2026-03-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.87M
Companies
2
Total Filings
89
Lifetime Open-Market Net
-$13.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BMRN | EVP, Chief Financial Officer | 123,314 | $63.81 | $7.87M | -$13.92M | 82 | 2026-03-19 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | Director | 1,250 | — | — | $0 | 6 | 2018-01-09 |
Recent Filings · Page 7 of 9
89 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-03 | BMRN | Tax (F) | −308 | -$38.7K | EDGAR |
| 2015-05-22 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-19 | BMRN | Tax (F) | −207 | -$25.4K | EDGAR |
| 2015-05-12 | BMRN | Mixed | +163 | -$22.9K | EDGAR |
| 2015-03-17 | BMRN | Grant (A) | +4,000 | $0 | EDGAR |
| 2015-03-05 | BMRN | Mixed | — | -$568.6K | EDGAR |
| 2015-03-05 | BMRN | Grant (A) | +4,000 | $0 | EDGAR |
| 2015-01-02 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-03 | BMRN | Mixed | — | -$799.4K | EDGAR |
| 2014-12-02 | BMRN | Sell (S) | −3,400 | -$302.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.